Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 40 recruiting now later-stage tilt #125 of 28,707 conditions

Migraine: later-stage trial registry

40 of 105 indexed Migraine trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #125 of 28,707 conditions by registered trial count.

105 US clinical trials · 40 currently recruiting · #125 of 28,707 conditions by registered trial count

Migraine: 105 US clinical trials tracked, 40 recruiting.

Migraine is the subject of 105 registered US clinical trials on ClinicalTrials.gov, 40 of them currently open to new participants. 33 are in Phase 3-4 (later-stage) and 20 in Phase 1-2 (earlier-stage). The most active sponsor is Pfizer, running 7 of these trials.

Enrollment posture brief

Registry condition migraine

OPEN 40 | RECR 38% | LATE 33 | EARLY 20 | RANK #125 | SPON 7

Nearest open-share peer: Behavior, Health (38% recruiting · 21 trials)

Autism46.7%Cognitive Impairment43.4%Migraine (this)38%Hematopoietic and Lymphoid C33.3%Schizoaffective Disorder29.5%
Open-enrollment share among volume-matched conditions near Migraine

Migraine lists 40 open slots (38% of 105 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Migraine on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Migraine recruits in line with its size-band peers.

    40 of 105 indexed trials (38.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Migraine trials is spread across many organizations.

    Pfizer accounts for 7 of 105 trials (6.7%). 59 distinct sponsors appear on at least one study for this condition label.

  3. Typical Migraine enrolment sits around 127 participants.

    Median target enrolment is 127 among the 103 trials that report a genuine target (sentinel values excluded). 42 of those (40.8%) plan for fewer than 100 participants.

  4. Migraine research is mostly interventional.

    85 interventional and 20 observational studies make up this index (81% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 18Phase 212Phase 320Phase 413

Phase Distribution

PhaseTrial count
Phase 1 8
Phase 2 12
Phase 3 20
Phase 4 13

Named interventions

Most-linked intervention names on Migraine records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
18 trials
Rimegepant Drug
6 trials
Galcanezumab Drug
4 trials
Erenumab Drug
3 trials
Fremanezumab Drug
3 trials
Pain ratings Behavioral
3 trials
Pressure stimuli Device
3 trials
Ubrogepant Drug
3 trials

US sites by state

Facility locations filed on Migraine trials. A trial with sites in several states counts in each.

California 35 trials
New York 26 trials
Florida 25 trials
Connecticut 18 trials
Arizona 17 trials
Missouri 16 trials
Illinois 16 trials
Ohio 14 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Migraine page

105 registered trials, 40 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 40 Migraine trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Pfizer sponsors the most Migraine trials on record, review their full trial history before evaluating a specific study. See Pfizer's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Migraine condition card totals 105 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.